Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Torasemide

Next Previous
X
Search
Drug Profile

Torasemide

Alternative Names: BM 02015; C 3534; C 3535; Demadex; Dilutol; GJ 1090; Isodiur; JDL 464; Luprac; Sutril; Toradiur; Torem; Toresmide; Torrem R; Torsemide; Trasemide; Unat; Zemide

Latest Information Update: 24 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Christiaens
  • Developer Christiaens; FUJIFILM Toyama Chemical; Laboratorios Novag; Mitsubishi Tanabe Pharma Corporation; Roche
  • Class Antihypertensives; Heart failure therapies; Small molecules; Sulfonamides
  • Mechanism of Action Loop diuretics; Sodium-potassium-chloride symporter inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Heart failure; Hypertension; Kidney disorders; Liver disorders

Most Recent Events

  • 05 Aug 2016 Meda has been acquired by Mylan
  • 24 Mar 2011 Generic equivalent approved in USA for oedema associated with Congestive heart failure, Renal disease or Hepatic disease
  • 15 Aug 2008 Meda acquires Torasemide for Heart failure from Roche

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top